These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 24618835

  • 1. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
    Chen J, Hou R, Zhang X, Ye Y, Wang Y, Tian J.
    PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835
    [Abstract] [Full Text] [Related]

  • 2. Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin.
    Chen J, Zhao X, Ye Y, Wang Y, Tian J.
    Cell Physiol Biochem; 2013; 32(6):1790-7. PubMed ID: 24355881
    [Abstract] [Full Text] [Related]

  • 3. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways.
    Zhao X, Li X, Ren Q, Tian J, Chen J.
    Gene; 2016 Oct 10; 591(1):123-128. PubMed ID: 27393650
    [Abstract] [Full Text] [Related]

  • 4. Calycosin induces apoptosis in osteosarcoma cell line via ERβ‑mediated PI3K/Akt signaling pathways.
    Tian W, Wang ZW, Yuan BM, Bao YG.
    Mol Med Rep; 2020 Jun 10; 21(6):2349-2356. PubMed ID: 32236598
    [Abstract] [Full Text] [Related]

  • 5. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
    Siraj MA, Jacobs AT, Tan GT.
    Chem Biol Interact; 2022 May 25; 359():109916. PubMed ID: 35346647
    [Abstract] [Full Text] [Related]

  • 6. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 7. Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.
    Zhang Y, Moerkens M, Ramaiahgari S, de Bont H, Price L, Meerman J, van de Water B.
    Breast Cancer Res; 2011 May 19; 13(3):R52. PubMed ID: 21595894
    [Abstract] [Full Text] [Related]

  • 8. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y, Hu S, Chen Y, Zhang X, Gao H, Tian J, Chen J.
    Phytomedicine; 2023 Sep 19; 118():154924. PubMed ID: 37393829
    [Abstract] [Full Text] [Related]

  • 9. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
    Fox EM, Kuba MG, Miller TW, Davies BR, Arteaga CL.
    Breast Cancer Res; 2013 Sep 19; 15(4):R55. PubMed ID: 23844554
    [Abstract] [Full Text] [Related]

  • 10. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Sun H, Yin M, Qian W, Yin H.
    Med Sci Monit; 2018 Sep 05; 24():6178-6186. PubMed ID: 30182951
    [Abstract] [Full Text] [Related]

  • 11. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
    Tian J, Wang Y, Zhang X, Ren Q, Li R, Huang Y, Lu H, Chen J.
    J Exp Clin Cancer Res; 2017 Nov 02; 36(1):153. PubMed ID: 29096683
    [Abstract] [Full Text] [Related]

  • 12. Calycosin suppresses colorectal cancer progression by targeting ERβ, upregulating PTEN, and inhibiting PI3K/Akt signal pathway.
    Zhu L, Liu S, Liao YF, Sheng YM, He JC, Cai ZX, Man Q, Wu YY.
    Cell Biol Int; 2022 Sep 02; 46(9):1367-1377. PubMed ID: 35842774
    [Abstract] [Full Text] [Related]

  • 13. Poly(ADP-ribose) polymerase as a novel regulator of 17β-estradiol-induced cell growth through a control of the estrogen receptor/IGF-1 receptor/PDZK1 axis.
    Kim H, Tarhuni A, Abd Elmageed ZY, Boulares AH.
    J Transl Med; 2015 Jul 17; 13():233. PubMed ID: 26183824
    [Abstract] [Full Text] [Related]

  • 14. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.
    Steroids; 2013 Nov 17; 78(11):1071-86. PubMed ID: 23891847
    [Abstract] [Full Text] [Related]

  • 15. Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.
    Lindberg K, Helguero LA, Omoto Y, Gustafsson JÅ, Haldosén LA.
    Breast Cancer Res; 2011 Apr 14; 13(2):R43. PubMed ID: 21492444
    [Abstract] [Full Text] [Related]

  • 16. Calycosin and genistein induce apoptosis by inactivation of HOTAIR/p-Akt signaling pathway in human breast cancer MCF-7 cells.
    Chen J, Lin C, Yong W, Ye Y, Huang Z.
    Cell Physiol Biochem; 2015 Apr 14; 35(2):722-8. PubMed ID: 25613518
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T, Gomes A.
    Chem Biol Interact; 2017 Apr 25; 268():119-128. PubMed ID: 28322778
    [Abstract] [Full Text] [Related]

  • 18. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP, Yang YX, Liu QL, Pan ST, He ZX, Zhang X, Yang T, Chen XW, Wang D, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Apr 25; 9():1627-52. PubMed ID: 25834401
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ, Fabris V, Doria ML, Lindberg K, Gustafsson JÅ, Amado F, Lanari C, Helguero LA.
    Oncogene; 2013 May 09; 32(19):2390-402. PubMed ID: 22751110
    [Abstract] [Full Text] [Related]

  • 20. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
    Chang HL, Sugimoto Y, Liu S, Wang LS, Huang YW, Ye W, Lin YC.
    Anticancer Res; 2009 Aug 09; 29(8):3195-205. PubMed ID: 19661335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.